It has been indicated that VEGFC or VEGFD can specifically bind vascular endothelial growth factor receptor-3 (VEGFR-3), as well as promote tumor lymphangiogenesis and prevent the spread of lymphatic tumor to regional lymph nodes [4, 9]. Here, FLT4 is linked to neoplasm.